Rothfuss Cristin sold SRPT
September 4, 2026 · Form 4 insider transaction
Rothfuss Cristin sold 22,025 shares of Sarepta Therapeutics, Inc. at $22.22 per share, a transaction worth $489.4K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
22,025
Price
$22.22
Total value
$489.4K
InsiderRothfuss Cristin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateSeptember 4, 2026
Filing dateSeptember 8, 2026
Shares owned after115,519
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.